Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease. - Wikidata - awgldk - TriplyDB

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

http://www.wikidata.org/entity/Q37682538

about

Prevalence of Anxiety among Hungarian Subjects with Parkinson's Disease.Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

P2860

Q42706737-983048F8-30E0-4005-BE14-9CE79ACC4C20 Q47290343-9BB46643-3A96-4670-8EC8-E7137D1C9E5B

P2860

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

http://www.wikidata.org/entity/Q37682538

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@en

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@nl

type

label

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@en

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@nl

prefLabel

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@en

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@nl

P1433

Q37682538-6B64DA75-DBB9-49A5-B5D8-BCDFD9FC8D55

P1476

Q37682538-8FA0DED9-E2C8-4BBB-80F6-0A155FB82788

P2093

Q37682538-189B7832-3A1E-44B7-871C-59B8A44AC036

Q37682538-1FB97478-55D2-4C92-B830-E273344B59CB

Q37682538-4F4C6265-DB4F-4293-BAEC-2DAFEFDC4F9E

Q37682538-A14B7764-05A2-4724-89A0-AE15D57F9396

Q37682538-E890DACD-905C-402D-8E70-32632EDE3EA5

Q37682538-E9FC771D-7BC7-4AC7-A947-981DF0AE5646

P2860

Q37682538-0609A42A-3D91-43CD-BE15-D020F6369FFB

Q37682538-0BF8804A-3B0D-46ED-A6E0-8CE9B72113E7

Q37682538-240AC573-55C1-4247-B436-F85391A0DED3

Q37682538-308F3A0C-F39E-4F40-8D7A-7E4CA8586B85

Q37682538-32BD4A04-1F49-4128-A280-EF56A3482E82

Q37682538-3B4CE131-C128-4BC0-8ABB-60081BA18332

Q37682538-3DE36194-25CE-4B59-96B2-F37A4A5A2E77

Q37682538-3EA48806-C3F3-48CD-A6F6-374731F2BBDB

Q37682538-3FAD909C-D57F-46F0-8449-370E7E75B302

Q37682538-419E6B3D-4F85-4D75-AAA6-7DC13F7F0D2E

P304

Q37682538-941D1DEA-967E-4ADF-887D-46C44A083281

P31

Q37682538-73B8DF15-FB2C-498A-86C5-53E83DE19E68

P356

Q37682538-40453D3C-BB9F-4C7A-822B-F3706F1E6A47

P478

Q37682538-1347728E-8687-42E7-8DA7-A1F96D88DAAE

P50

Q37682538-3F1E39C6-77EE-4E19-B971-C161861E7C1C

Q37682538-7225D531-45E4-48D9-AB28-58BF289240DF

Q37682538-82AF2B20-92D2-46CA-B024-6E96B7E3F5FE

P577

Q37682538-DEED5D23-5A81-42FD-B174-1524FE4B6722

P698

Q37682538-D05A6F61-5A5B-489D-B740-85D1350A0A53

P921

Q37682538-C9F92426-52EA-460D-9206-84301F92AF07

P932

Q37682538-FE70E2CD-88C5-4BC9-B410-BEFA3F31DF7C

P356

J.PARKRELDIS.2017.01.001

P1433

Parkinsonism and Related Disorders

P1476

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

@en

P2093

David P Breen

http://www.w3.org/2001/XMLSchema#string

Gordon W Duncan

http://www.w3.org/2001/XMLSchema#string

ICICLE-PD study group

http://www.w3.org/2001/XMLSchema#string

Nadeeka N W Dissanayaka

http://www.w3.org/2001/XMLSchema#string

Rachael A Lawson

http://www.w3.org/2001/XMLSchema#string

Tien K Khoo

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Parkinsonism: onset, progression and mortality

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Development and validation of a geriatric depression screening scale: a preliminary report

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Parkinson's disease: the quintessential neuropsychiatric disorder

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.

Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.

P304

63-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PARKRELDIS.2017.01.001

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Alison J. Yarnall

Roger A. Barker

P577

2017-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28108263

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5338650

http://www.w3.org/2001/XMLSchema#string